Subscribe to Newsletter
Manufacture Business Practice

Assessing the effect of formulation composition on spidroin charge and stability

Work performed in conjunction with Spiber Technologies, Uppsala, Sweden. Use of dynamic and electrophoretic light scattering to assess the effects of protein formulation composition

Manufacture Business Practice

Catapulted to the Top

Sitting Down With... Keith Thompson, CEO of the Cell and Gene Therapy Catapult, UK.

Manufacture Drug Delivery

Ready to Break the Mold?

| Sponsored by Schott

Pharma suppliers are teaming up to take ready-to-use technology to the next level.

Manufacture Analytical Science

From UV to MIR: the biomass monitoring spectrum

| Dörte Solle, Philipp Biechele, Christoph Busse and Thomas Scheper

Can sophisticated (spectroscopic) sensors streamline bioprocess monitoring to better meet FDA standards?

Manufacture Analytical Science

Not Spoiling the (Biopharma) Broth

| Dörte Solle, Philipp Biechele, Christoph Busse and Thomas Scheper

Can sophisticated (spectroscopic) sensors streamline bioprocess monitoring to better meet FDA standards?

Discovery & Development Drug Delivery

Micro-Formulating for Dermal Drug Delivery

| Sponsored by BASF

Industry is beginning to appreciate how formulation microstructure makes a fundamental contribution to dermal drug delivery – and this new understanding emphasizes the key role of excipients.

Discovery & Development Business Practice

The Numbers Game

Statisticians are vital in the pharma industry, but rarely do they receive public fanfare for their work. The Award for Statistical Excellence in the Pharmaceutical Industry aims to change the status quo.

Discovery & Development

The Shape of Proteins to Come

A new technique allows scientists to see conformational changes caused by ligand binding in real time, opening up new screening options for drug discovery.

Manufacture Facilities

Fumigation of the Future

| Andrew Ramage

A choice of fumigants are available for fumigating microbiological safety cabinets and high-level containment rooms. One substance that is still used in the industry is formaldehyde, but given that formaldehyde is toxic, carcinogenic and corrosive, you’d be better looking for alternatives.

Discovery & Development Business Practice

The Bright Star of Open Innovation

| Niclas Nilsson

Pharma companies are notoriously protective of their intellectual property, so it’s a big deal to open up and give knowledge away for free. Nevertheless, it is the path that LEO Pharma took with its Open Innovation platform – and they’ve learnt that, if you give a little away, you can expect much in return.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register